Olema enters 7-year lease for ~38K sq ft corporate HQ in San Francisco

Olema Pharmaceuticals, Inc.

Lease with KR Oyster Point II, LLC for 38,176 sq ft on 4th and 5th floors.
Base rent for Phase I (25,048 sq ft) is $12,361,188 over initial term.
Base rent for Phase II (13,128 sq ft) is $6,145,463.76 over initial term.
Initial term 7 years; one-time termination option at 60 months with $1,716,240.96 fee.
Cash security deposit of $427,546.80 required; move-in expected by December 2026.

item 1.01 item 2.03

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Olema Pharmaceuticals, Inc. entered into Lease with KR Oyster Point II, LLC (effective 2026-04-27).

Action: entry
Agreement: lease
Counterparty: KR Oyster Point II, LLC
Effective: 2026-04-27

Exact text from the filing

On April 27, 2026, Olema Pharmaceuticals, Inc. (the “Company”) entered into a lease agreement (the “Lease”) with KR Oyster Point II, LLC, a Delaware limited liability company (the “Landlord”)

View on SEC.gov

Browse all material agreements →

Olema Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-26-201751

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.